GSVCX
Price
$14.76
Change
+$0.14 (+0.96%)
Updated
Jun 6 closing price
Net Assets
424.61M
VIVAX
Price
$67.51
Change
+$0.65 (+0.97%)
Updated
Jun 6 closing price
Net Assets
188.77B
Interact to see
Advertisement

GSVCX vs VIVAX

Header iconGSVCX vs VIVAX Comparison
Open Charts GSVCX vs VIVAXBanner chart's image
Goldman Sachs Large Cap Value C
Price$14.76
Change+$0.14 (+0.96%)
VolumeN/A
Net Assets424.61M
Vanguard Value Index I
Price$67.51
Change+$0.65 (+0.97%)
VolumeN/A
Net Assets188.77B
GSVCX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSVCX vs. VIVAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. GSVCX (425M). VIVAX pays higher dividends than GSVCX: VIVAX (2.16) vs GSVCX (0.32). GSVCX was incepted earlier than VIVAX: GSVCX (25 years) vs VIVAX (33 years). GSVCX (2.00) is less costly to investors than VIVAX (0.17). GSVCX is a more actively managed with annual turnover of: 51.00 vs. VIVAX (9.00). GSVCX has a lower initial minimum investment than VIVAX: GSVCX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.81 vs. GSVCX (-3.67). VIVAX return over 5 years is better than : 58.70 vs. GSVCX (14.31).
GSVCXVIVAXGSVCX / VIVAX
Total Expense Ratio1.750.171,029%
Annual Report Gross Expense Ratio2.000.171,176%
Fund Existence25 years33 years-
Gain YTD0.4121.23833%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets425M189B0%
Annual Yield % from dividends0.322.1615%
Returns for 1 year-3.676.81-54%
Returns for 3 years-0.4818.51-3%
Returns for 5 years14.3158.7024%
Returns for 10 years-13.02102.90-13%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABUS3.480.08
+2.35%
Arbutus Biopharma Corp
WSFS53.081.21
+2.33%
WSFS Financial Corp
MNSB18.20N/A
N/A
MainStreet Bancshares
PATH13.21-0.05
-0.38%
UiPath
FAMI1.87-0.06
-3.11%
Farmmi Inc